Roubaix Capital LLC purchased a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm purchased 8,112 shares of the medical research company’s stock, valued at approximately $2,275,000. Several other hedge funds and other institutional investors have also […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.